Fundz

CryoLogyx completed £500k in a seed funding round led by private UK business angels and Wider Oxford Technology Angel Network to support commercialization of cryopreserved cell technology.

PRIVATEMar 18, 2024

Amount Raised

£500,000

Round Type

Seed

Biotechnology

Investors

Wider Oxford Technology Angel NetworkPrivate Uk Business Angels

Description

CryoLogyx, a University of Warwick spinout, announced the completion of an oversubscribed seed funding round, raising £500k GBP from private UK business angels and the Wider Oxford Technology Angel Network (WOTAN). The funding will be used to support commercialization of the company’s innovative cryopreserved cell technology.

Quick answer

CryoLogyx raised £500,000 in a Seed round, dated March 18, 2024. Investors: Wider Oxford Technology Angel Network and Private Uk Business Angels.

How much did CryoLogyx raise?
CryoLogyx raised £500,000 in a Seed round on March 18, 2024.
Who invested in CryoLogyx?
Wider Oxford Technology Angel Network and Private Uk Business Angels are named as investors in this round.
What does CryoLogyx do?
CryoLogyx is an early-stage biotechnology company which is developing frozen ready-to-use cells for the medicines discovery, diagnostics and cell-therapy industries based in Coventry, UK.
Who are the decision-makers at CryoLogyx?
Fundz holds 1 contact at CryoLogyx. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as CryoLogyx that raised within 45 days of this round, from Fundz verified event records.

  • Livara Health raised $15M (Series B) on May 2, 2024.
  • Novocure raised $400M (Debt Financing) on May 2, 2024.
  • Delphia Therapeutics raised $67M (Series A) on May 2, 2024.
  • Karius® raised $100M (Series C) on May 2, 2024.
  • Ikerian raised $6.2M (Series A) on May 2, 2024.
  • Latus Bio raised $54M (Series A) on May 2, 2024.

Who to call at CryoLogyx, and when

A new round usually means CryoLogyx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CryoLogyx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CryoLogyx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CryoLogyx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CryoLogyx

About

CryoLogyx is an early-stage biotechnology company which is developing frozen ready-to-use cells for the medicines discovery, diagnostics and cell-therapy industries based in Coventry, UK. With our exclusive technology, we are revolutionizing the freezing, storage, and transportation of cells. Our innovation ensures the delivery of viable cells and cell therapies in the preferred format, ready for use whenever our users need them.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CryoLogyx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for CryoLogyx's next move

See what Strategic adds

CryoLogyx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.